OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Formin protein DIAPH1 positively regulates PD-L1 expression and predicts the therapeutic response to anti-PD-1/PD-L1 immunotherapy
Jie Mei, Yun Cai, Huiyu Wang, et al.
Clinical Immunology (2022) Vol. 246, pp. 109204-109204
Closed Access | Times Cited: 14

Showing 14 citing articles:

Deep Learning-Based, Multiclass Approach to Cancer Classification on Liquid Biopsy Data
Maksym A. Jopek, Krzysztof Pastuszak, Sebastian Cygert, et al.
IEEE Journal of Translational Engineering in Health and Medicine (2024) Vol. 12, pp. 306-313
Open Access | Times Cited: 8

CD47 is a tumor cell-derived exosomal signature and regulates tumor immune microenvironment and immunotherapy responses
Yifei Luan, Yinghui Zhang, Shangjin Li, et al.
Translational Oncology (2025) Vol. 53, pp. 102291-102291
Open Access | Times Cited: 1

SECTM1 is upregulated in immuno-hot tumors and predicts immunotherapeutic efficacy in multiple cancers
Jie Mei, Ziyi Fu, Yun Cai, et al.
iScience (2023) Vol. 26, Iss. 2, pp. 106027-106027
Open Access | Times Cited: 13

Formin protein DAAM1 positively regulates PD-L1 expression via mediating the JAK1/STAT1 axis in pancreatic cancer
Rui Xu, Mengyun Wan, Jiadong Pan, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access

Protocol to identify novel immunotherapy biomarkers based on transcriptomic data in human cancers
Jie Mei, Yun Cai, Rui Xu, et al.
STAR Protocols (2023) Vol. 4, Iss. 2, pp. 102258-102258
Open Access | Times Cited: 10

The heterogeneity of tumour immune microenvironment revealing the CRABP2/CD69 signature discriminates distinct clinical outcomes in breast cancer
Jie Mei, Yun Cai, Lingyan Chen, et al.
British Journal of Cancer (2023) Vol. 129, Iss. 10, pp. 1645-1657
Open Access | Times Cited: 9

Advances in understanding the roles of actin scaffolding and membrane trafficking in dendrite development
Wanting Wang, Menglong Rui
Journal of genetics and genomics/Journal of Genetics and Genomics (2024) Vol. 51, Iss. 11, pp. 1151-1161
Closed Access | Times Cited: 1

Formin protein FMNL1 is a biomarker for tumor-infiltrating immune cells and associated with well immunotherapeutic response
Guomin Lu, Hui Wang, Rui‐Hua Xu, et al.
Journal of Cancer (2023) Vol. 14, Iss. 16, pp. 2978-2989
Open Access | Times Cited: 2

Lovastatin-mediated pharmacological inhibition of Formin protein DIAPH1 suppresses tumor immune escape and boosts immunotherapy response
Mengyun Wan, Ji Zhou, Ning Xue, et al.
International Immunopharmacology (2024) Vol. 144, pp. 113637-113637
Closed Access

Editorial: Multi-omics analysis in tumor microenvironment and tumor heterogeneity
Yuxin Shi, Qinglin Zhang, Jie Mei, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access

Page 1

Scroll to top